For Immediate Release: December 20, 2024 Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults… [+4616 chars]Read More
FDA Approves First Medication for Obstructive Sleep Apnea FDAgov
